Remote Jobs at Evozyne

Evozyne

51 - 200 employees

Founded 2020

🧬 Biotechnology

💊 Pharmaceuticals

🤖 Artificial Intelligence

💰 $81M Series B - Evozyne on 2023-09

Biotechnology • Pharmaceuticals • Artificial Intelligence

Evozyne is an AI-native biotechnology company that designs de novo therapeutic proteins to treat immune‑mediated diseases. Its EvoGen generative AI engine designs protein sequences optimized for potency, stability, specificity, and low immunogenicity, and its EvoLab high-throughput experimental facility builds and tests thousands of candidates each design cycle to generate proprietary data. Evozyne advances engineered proteins—including IgG proteases, next‑generation cytokines, and respiratory disease candidates—toward clinical evaluation to address patients who do not respond to existing biologics or small molecules.